New! Sign up for our free email newsletter.
Science News
from research organizations

MRI Brain Scans Accurate In Early Diagnosis Of Alzheimer's Disease

Date:
December 23, 2008
Source:
University of South Florida Health
Summary:
MRI brain scans should be included as a diagnostic test for early Alzheimer's disease, experts conclude.
Share:
FULL STORY

MRI scans that detect shrinkage in specific regions of the mid-brain attacked by Alzheimer’s disease accurately diagnose the neurodegenerative disease, even before symptoms interfere with daily function, a study by the Florida Alzheimer’s Disease Research Center (ADRC) in Miami and Tampa found.

The study, reported earlier this month in the journal Neurology, adds to a growing body of evidence indicating MRI brain scans provide valuable diagnostic information about Alzheimer’s disease.

The findings are important in light of many new disease-modifying drugs in trials -- treatments that may prevent mild memory loss from advancing to full-blown dementia if administered early enough.

"We advocate, based on these findings, that the criteria for the diagnosis of Alzheimer’s disease should include MRI scans,” said the study’s lead author Ranjan Duara, MD, medical director of the Wien Center for Alzheimer’s Disease and Memory Disorders at Mount Sinai Medical Center who is affiliated with the University of Miami Miller School of Medicine and University of South Florida College of Medicine. “By incorporating MRIs into the assessment of patients with memory problems, early diagnosis can be standardized and done far more accurately.”

“This study demonstrates that MRI brain scans are accurate enough to be clinically useful, both in diagnosing Alzheimer’s disease itself at an early stage and in identifying people at risk of developing Alzheimer’s,” said Florida ADRC Director Huntington Potter, PhD, a neuroscientist at the Byrd Alzheimer’s Center and Research Institute, University of South Florida.

Alzheimer’s disease, the most common cause of dementia, is characterized by memory loss, disorientation, difficulty with reasoning and the decline of language and thinking skills. Alzheimer’s is diagnosed by a process of elimination since many other diseases and related disorders can mimic its symptoms, and autopsy is currently the only definitive way a diagnosis can be confirmed. The diagnosis often includes a medical history, mental status tests, neurological evaluations and blood tests. Physicians typically use brain scans only to exclude conditions that can also cause memory deficits, such as strokes and brain tumors.

The Florida researchers used a new visual rating system to evaluate the severity of shrinkage, or atrophy, in the brain’s medial temporal lobe – specifically in three structures essential for the conscious memory of facts and events. They compared the MRI brain scans of 260 people -- a group with probable Alzheimer’s disease, two groups with varying degrees of mild cognitive impairment (mild memory problems), and a control group of normal elderly with no discernable memory loss. They found that scores generated by this MRI-facilitated test accurately distinguished each group from the other and correlated with the types of memory problems most frequently caused by Alzheimer’s disease. The more extensive the brain atrophy, the more advanced the clinical stage of Alzheimer’s disease.

The researchers even found brain atrophy in some people without memory complaints at the study’s onset who demonstrated memory decline when assessed a year or two later. This suggests MRIs could predict who will get the disease well before signs of dementia become apparent by other diagnostic methods as well as rule out an Alzheimer’s diagnosis in people experiencing memory problems, Dr. Duara said.

“If you don’t have changes in these three particular areas of the brain, then you don’t have Alzheimer’s, Dr. Duara said.

Researchers at centers like Miami’s Wien Center and USF’s Byrd Institute are developing new Alzheimer’s drugs that attack mechanisms leading to the death of nerve cells and their connections. The emergence of these disease-modifying treatments has made an earlier diagnosis of Alzheimer’s increasingly important, Dr. Duara said. “Having an accurate diagnosis will allow us to start using drugs earlier. The earlier treatment begins, the more likely you are to stop disease progression and benefit the patient.”

Most participants in the MRI study were enrolled in the clinical arm of the Florida ADRC, which is supported by a grant from the National Institute on Aging.


Story Source:

Materials provided by University of South Florida Health. Note: Content may be edited for style and length.


Cite This Page:

University of South Florida Health. "MRI Brain Scans Accurate In Early Diagnosis Of Alzheimer's Disease." ScienceDaily. ScienceDaily, 23 December 2008. <www.sciencedaily.com/releases/2008/12/081218213630.htm>.
University of South Florida Health. (2008, December 23). MRI Brain Scans Accurate In Early Diagnosis Of Alzheimer's Disease. ScienceDaily. Retrieved March 28, 2024 from www.sciencedaily.com/releases/2008/12/081218213630.htm
University of South Florida Health. "MRI Brain Scans Accurate In Early Diagnosis Of Alzheimer's Disease." ScienceDaily. www.sciencedaily.com/releases/2008/12/081218213630.htm (accessed March 28, 2024).

Explore More

from ScienceDaily

RELATED STORIES